CYRAMZA INJECTION*


Brand:
CYRAMZA INJECTION*

Manufacturer:
ELY LILLY AND CO.

  
Compositions:
Ramucirumab- mg injection,
  
Strength Rate Packing Style
mg 0.00 unit injection

List of Related Indications:
  • Combination with Docetaxel for Metastatic Non-small Lung Cancer (NSCLC) with disease progression after Platinum-based Chemotherapy

List Of Drugs:
  • Ramucirumab- @-Cyramza Injection (with Docetaxel) (Dec 2014) - Anti-cancer

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation